Tsai Chen Lung's Form 4 filing
CapsoVision, Inc (CV) · filed Jul 7, 2025
- Accession no.
- 0000950170-25-094309
- Filed
- Jul 7, 2025
- Trade date
- Jul 3, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 4 derivative transactions. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001307275-26-000002 (Feb 6, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tsai Chen LungCIK 0001307275 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Common Stock | CConversionAcquired | +91,432 | –F1 | – | 115,456 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Common Stock | CConversionDisposed | −21,450 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −16,683 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −26,112 | $0.00 | $0 | 0 | Indirect | |
| Jul 3, 2025 | Common Stock | CConversionDisposed | −27,187 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Series B preferred stock, Series D-1 preferred stock, Series E preferred stock and Series H preferred stock automatically converted into approximately 0.3003 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The number of shares reported herein gives effect to a 1-for-3.33 reverse stock split of the Issuer's common stock effected by the Issuer on July 2, 2025 in connection with its initial public offering.
Referenced by the price of 1 transaction in Table I.